We scan new podcasts and send you the top 5 insights daily.
Medical lab test ranges define 'normal' by the average of the current population. In a society where 75% are overweight, this standard is not optimal. This creates a false sense of security, as being 'normal' might still mean being on a trajectory toward chronic disease.
Despite being a cheap and powerful early indicator of metabolic dysfunction, insulin levels are rarely checked by physicians. High insulin can signal a health crisis long before blood sugar levels rise, yet the medical system overlooks it, focusing on late-stage indicators like A1C.
Body Mass Index (BMI) is an imperfect tool for risk assessment. A patient can have a normal BMI but a high percentage of body fat—a condition called "normal weight obesity." This is a significant, yet often overlooked, risk factor for both breast cancer development and recurrence.
There has been a significant population-level decline in male testosterone. The average level dropped from around 600 ng/dL in the late 1990s to 450 ng/dL by 2015. This is linked to modern lifestyle factors like rising obesity, endocrine-disrupting chemicals, and ultra-processed diets.
Many chronic illnesses, including high blood pressure, cancer, and cognitive decline, are not separate issues but symptoms of a single underlying problem: chronically elevated insulin levels. This metabolic “trash” accumulates over years, making the body a breeding ground for disease.
You don't have to be overweight to have dangerous levels of visceral fat surrounding your organs. These individuals, often called "metabolically unhealthy lean," appear healthy but have biomarkers similar to obese people, posing significant health risks they are unaware of.
Standard BMI categories fail to capture the elevated diabetes risk in certain ethnic groups. Clinicians must recognize that patients of South Asian, Korean, or Chinese descent are at higher risk for hyperglycemia at a much lower BMI (e.g., a BMI of 23 should be considered overweight).
Advanced health tech faces a fundamental problem: a lack of baseline data for what constitutes "optimal" health versus merely "not diseased." We can identify deficiencies but lack robust, ethnically diverse databases defining what "great" health looks like, creating a "North Star" problem for personalization algorithms.
Only 7% of US citizens are metabolically healthy, meaning 93% have at least one biomarker of metabolic syndrome (e.g., pre-diabetes, high blood pressure, abdominal obesity). This widespread metabolic ill-health provides a strong biological basis for the escalating mental health crisis.
Long before disease symptoms or abnormal lab results appear, subtle declines in balance, gait, and reaction time are already determining your long-term healthspan. These functional metrics are the true leading indicators of future health, not genetics or bloodwork.
Counterintuitively, if your blood sugar doesn't spike after consuming sugar, it may not mean you're healthy. It could indicate your body is overproducing insulin to compensate, a sign of advanced insulin resistance which often precedes prediabetes.